Camurus receives Lund Municipality’s Business Award 2025

Camurus has been awarded Lund Municipality’s Business Award 2025 at the Lund Grand Prix, held on April 22 at The Loop in Science Village, Lund, Sweden.

The award recognizes companies that make a significant contribution to the development of the local business community. In its citation, the jury highlighted among other things (translated): “The winner of the City of Lund’s Business Award 2025 is a vibrant thirty‑year‑old that has transformed advanced research into pharmaceutical treatments that make life easier for patients with severe and chronic diseases.”/…/“With Lund as a springboard, the company continues its journey, demonstrating that innovation and sustainability not only can coexist, but can actively drive one another forward.”

The award was presented in connection with the Lund Grand Prix, an annual event that brings together businesses, entrepreneurs, and decision-makers to highlight innovation, collaboration, and future-focused initiatives in the region.

Read the full press release from Lund Municipality: Sex priser delades ut på Lund Grand Prix (In Swedish)

About Camurus
Camurus is an international, science-led biopharmaceutical company committed to developing and commercializing innovative, long-acting medicines for improving the lives of patients with severe and chronic diseases. New drug products with best-in-class potential are conceived based on the company’s proprietary FluidCrystal^® technology and its extensive R&D expertise. The R&D pipeline includes products for the treatment of dependence, pain, cancer, and endocrine diseases. Camurus has operations across Europe, the US, and Australia, with headquarters in Lund, Sweden. The company’s shares are listed on Nasdaq Stockholm under the ticker CAMX. For more information, visit www.camurus.com and LinkedIn.